GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Stem Holdings Inc (OTCPK:STMH) » Definitions » Net Current Asset Value

Stem Holdings (Stem Holdings) Net Current Asset Value : $-0.62 (As of Sep. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Stem Holdings Net Current Asset Value?

In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).

Stem Holdings's net current asset value per share for the quarter that ended in Sep. 2023 was $-0.62.

The historical rank and industry rank for Stem Holdings's Net Current Asset Value or its related term are showing as below:

During the past 8 years, the highest Price-to-Net-Current-Asset-Value Ratio of Stem Holdings was 0.31. The lowest was 0.31. And the median was 0.31.

STMH's Price-to-Net-Current-Asset-Value is not ranked *
in the Drug Manufacturers industry.
Industry Median: 5.15
* Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.

Stem Holdings Net Current Asset Value Historical Data

The historical data trend for Stem Holdings's Net Current Asset Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stem Holdings Net Current Asset Value Chart

Stem Holdings Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Net Current Asset Value
Get a 7-Day Free Trial -10.26 -21.62 -1.65 6.84 -0.62

Stem Holdings Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Net Current Asset Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.84 -5.14 -5.09 -4.39 -0.62

Competitive Comparison of Stem Holdings's Net Current Asset Value

For the Drug Manufacturers - Specialty & Generic subindustry, Stem Holdings's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stem Holdings's Price-to-Net-Current-Asset-Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Stem Holdings's Price-to-Net-Current-Asset-Value distribution charts can be found below:

* The bar in red indicates where Stem Holdings's Price-to-Net-Current-Asset-Value falls into.



Stem Holdings Net Current Asset Value Calculation

Stem Holdings's Net Current Asset Value (NCAV) per share for the fiscal year that ended in Sep. 2023 is calculated as

Net Current Asset Value Per Share(A: Sep. 2023 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(13.319-13.978-1.087-0)/2.81009
=-0.62

Stem Holdings's Net Current Asset Value (NCAV) per share for the quarter that ended in Sep. 2023 is calculated as

Net Current Asset Value Per Share(Q: Sep. 2023 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(13.319-13.978-1.087-0)/2.81009
=-0.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Stem Holdings  (OTCPK:STMH) Net Current Asset Value Explanation

Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."

The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]

Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham’s strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.


Stem Holdings Net Current Asset Value Related Terms

Thank you for viewing the detailed overview of Stem Holdings's Net Current Asset Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Stem Holdings (Stem Holdings) Business Description

Traded in Other Exchanges
Address
2201 NW Corporate Boulevard, Suite 205, Boca Raton, FL, USA, 33431
Stem Holdings Inc is involved in a cannabis business. The company is engaged in the manufacture, possession, sale, distribution, and branding of cannabis and its related products. Its brand includes TJ's Gardens; Yerba Buena; Cannavore; Dose-ology and Travis X James.
Executives
Matthew Cohen director, officer: CEO & CFO 1702 COSTA DEL SOL, BOCA RATON FL 33432
Brian John Hayek director 7012 GIRARD ST, MCLEAN VA 22101
Diener Robert Louis Benjamin director 41ULUA PLACE, HAIKU HI 96708
Dennis Suskind director ONE NORTH END AVENUE, WORLD FINANCIAL CENTER, NEW YORK NY 10282
Rajiv Raj director 438B WOBURN AVE, TORONTO A6 M5M1L7
Jessica Michelle Feingold director 3730 W. 24TH AVE, DENVER CO 80211
Lindy L Sinder director 408 BARGARA LANE, BRYN MAWR PA 19010
Garrett Martin Bender director 506 ANDREWS AVENUE, DELRAY BEACH FL 33483
Adam Berk director, officer: President 9370 GRAND ESTATES WAY, BOCA RATON FL 33496
Steven Shelly Hubbard director, officer: CFO 3496 FARIVIEW WAY, WEST LINN OR 97068

Stem Holdings (Stem Holdings) Headlines